Year |
Citation |
Score |
2019 |
Negi A, Reilly CO, Jarikote DV, Zhou J, Murphy PV. Multi-targeting protein-protein interaction inhibitors: Evolution of macrocyclic ligands with embedded carbohydrates (MECs) to improve selectivity. European Journal of Medicinal Chemistry. 176: 292-309. PMID 31112891 DOI: 10.1016/J.Ejmech.2019.04.064 |
0.349 |
|
2019 |
Negi A, Zhou J, Sweeney S, Murphy PV. Ligand design for somatostatin receptor isoforms 4 and 5. European Journal of Medicinal Chemistry. 163: 148-159. PMID 30503939 DOI: 10.1016/J.Ejmech.2018.11.030 |
0.318 |
|
2018 |
Zhou J, Negi A, Mirallai SI, Warta R, Herold-Mende C, Carty MP, Ye XS, Murphy PV. N-Alkyl-1,5-dideoxy-1,5-imino-l-fucitols as fucosidase inhibitors: Synthesis, molecular modelling and activity against cancer cell lines. Bioorganic Chemistry. 84: 418-433. PMID 30554081 DOI: 10.1016/J.Bioorg.2018.12.003 |
0.308 |
|
2015 |
Negi A, Alex JM, Amrutkar SM, Baviskar AT, Joshi G, Singh S, Banerjee UC, Kumar R. Imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via selective topoisomerase-II-α inhibition. Bioorganic & Medicinal Chemistry. PMID 26216018 DOI: 10.1016/J.Bmc.2015.07.020 |
0.379 |
|
2015 |
Chauhan M, Rana A, Alex JM, Negi A, Singh S, Kumar R. Design, microwave-mediated synthesis and biological evaluation of novel 4-aryl(alkyl)amino-3-nitroquinoline and 2,4-diaryl(dialkyl)amino-3-nitroquinolines as anticancer agents. Bioorganic Chemistry. 58: 1-10. PMID 25462621 DOI: 10.1016/J.Bioorg.2014.11.004 |
0.346 |
|
2014 |
Kumar D, Kaur G, Negi A, Kumar S, Singh S, Kumar R. Synthesis and xanthine oxidase inhibitory activity of 5,6-dihydropyrazolo/pyrazolo[1,5-c]quinazoline derivatives. Bioorganic Chemistry. 57: 57-64. PMID 25222504 DOI: 10.1016/J.Bioorg.2014.08.007 |
0.341 |
|
Show low-probability matches. |